LongAteTM is a long acting Factor VIII treatment which is administered intravenously. This product has marketing approval in Russia.

This product is a plasma derived FVIII, which in common with rFVIII is delivered lyophilised and is reconstituted with Water For Injection (‘WFI’) including the PEGLip Chaperone, rather than just plain WFI.